Blau Farmacêutica S.A. (BLAU3.SA)

BRL 12.57

(-5.42%)

Net Income Summary of Blau Farmacêutica S.A.

Blau Farmacêutica S.A.'s latest annual net income in 2023 was 249.8 Million BRL , down -31.25% from previous year.
Blau Farmacêutica S.A.'s latest quarterly net income in 2024 Q2 was 48.73 Million BRL , up 21.56% from previous quarter.
Blau Farmacêutica S.A. reported an annual net income of 363.36 Million BRL in 2022, up 11.73% from previous year.
Blau Farmacêutica S.A. reported an annual net income of 325.22 Million BRL in 2021, up 27.87% from previous year.
Blau Farmacêutica S.A. reported a quarterly net income of 40.09 Million BRL for 2024 Q1, up 44.86% from previous quarter.
Blau Farmacêutica S.A. reported a quarterly net income of 99.39 Million BRL for 2023 Q3, up 40.41% from previous quarter.

Annual Net Income Chart of Blau Farmacêutica S.A. (2023 - 2015)

Historical Annual Net Income of Blau Farmacêutica S.A. (2023 - 2015)

Year	Net Income	Net Income Growth
2023	249.8 Million BRL	-31.25%
2022	363.36 Million BRL	11.73%
2021	325.22 Million BRL	27.87%
2020	254.33 Million BRL	27.01%
2019	200.23 Million BRL	62.46%
2018	123.25 Million BRL	19.51%
2017	103.12 Million BRL	218.96%
2016	32.33 Million BRL	40.2%
2015	23.06 Million BRL	0.0%

Year	Net Income	Net Income Growth
2024 Q2	48.73 Million BRL	21.56%
2024 Q1	40.09 Million BRL	44.86%
2023 Q3	99.39 Million BRL	40.41%
2023 Q1	51.95 Million BRL	-45.3%
2023 Q2	70.78 Million BRL	36.26%
2023 Q4	27.67 Million BRL	-72.16%
2023 FY	249.8 Million BRL	-31.25%
2022 FY	363.36 Million BRL	11.73%
2022 Q4	94.98 Million BRL	0.48%
2022 Q3	94.52 Million BRL	-15.9%
2022 Q2	112.4 Million BRL	82.88%
2022 Q1	61.46 Million BRL	36.06%
2021 Q4	45.17 Million BRL	-52.14%
2021 Q1	86.16 Million BRL	16.96%
2021 Q3	94.39 Million BRL	-5.13%
2021 Q2	99.49 Million BRL	15.47%
2021 FY	325.22 Million BRL	27.87%
2020 Q2	73.75 Million BRL	134.82%
2020 FY	254.33 Million BRL	27.01%
2020 Q4	73.67 Million BRL	-2.42%
2020 Q3	75.49 Million BRL	2.37%
2020 Q1	31.4 Million BRL	-45.46%
2019 Q3	51.45 Million BRL	-17.43%
2019 Q2	62.31 Million BRL	115.74%
2019 Q1	28.88 Million BRL	-33.02%
2019 FY	200.23 Million BRL	62.46%
2019 Q4	57.58 Million BRL	11.91%
2018 Q2	15.01 Million BRL	-33.8%
2018 FY	123.25 Million BRL	19.51%
2018 Q4	43.12 Million BRL	1.6%
2018 Q3	42.44 Million BRL	182.71%
2018 Q1	22.67 Million BRL	0.0%
2017 FY	103.12 Million BRL	218.96%
2016 FY	32.33 Million BRL	40.2%
2015 FY	23.06 Million BRL	0.0%

Peer Net Income Comparison of Blau Farmacêutica S.A.

Name	Net Income	Net Income Difference
Hypera S.A.	1.64 Billion BRL	84.841%